disodium 2-[(2-carboxylatophenyl)amino]-4-chlorobenzoate
Title | Journal |
---|---|
Identifying mechanism-of-action targets for drugs and probes. | Proceedings of the National Academy of Sciences of the United States of America 20120710 |
Estimation of the percolation thresholds in ternary lobenzarit disodium-dextran-HPMC hydrophilic matrices tablets: effects of initial porosity. | European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20091105 |
Investigation of the influence of particle size on the excipient percolation thresholds of HPMC hydrophilic matrix tablets. | Journal of pharmaceutical sciences 20071001 |
Estimation of the percolation thresholds in lobenzarit disodium native dextran matrix tablets. | AAPS PharmSciTech 20071001 |
Study of the critical points in lobenzarit disodium hydrophilic matrices for controlled drug delivery. | Chemical & pharmaceutical bulletin 20060501 |
Application of a new mathematical method for the estimation of the mean surface area to calculate the percolation threshold of lobenzarit disodium [correction of dissodium] salt in controlled release matrices. | Chemical & pharmaceutical bulletin 20040701 |
Alpha-methyldopa-type autoimmune hemolytic anemia caused by lobenzarit disodium of a mefenamic acid derivative and immunomodulator. | Blood 19940515 |